- Home
- ADVM vs AMPG Comparison
ADVM vs AMPG Comparison
Compare ADVM & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- AMPG
- Stock Information
- Founded
- ADVM 2006
- AMPG 2002
- Country
- ADVM United States
- AMPG United States
- Employees
- ADVM N/A
- AMPG N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- AMPG Telecommunications Equipment
- Sector
- ADVM Health Care
- AMPG Telecommunications
- Exchange
- ADVM Nasdaq
- AMPG Nasdaq
- Market Cap
- ADVM 47.4M
- AMPG 46.7M
- IPO Year
- ADVM 2014
- AMPG N/A
- Fundamental
- Price
- ADVM $2.39
- AMPG $2.10
- Analyst Decision
- ADVM Strong Buy
- AMPG Strong Buy
- Analyst Count
- ADVM 5
- AMPG 1
- Target Price
- ADVM $23.80
- AMPG $5.00
- AVG Volume (30 Days)
- ADVM 338.5K
- AMPG 190.7K
- Earning Date
- ADVM 08-11-2025
- AMPG 08-13-2025
- Dividend Yield
- ADVM N/A
- AMPG N/A
- EPS Growth
- ADVM N/A
- AMPG N/A
- EPS
- ADVM N/A
- AMPG N/A
- Revenue
- ADVM $1,000,000.00
- AMPG $10,814,140.00
- Revenue This Year
- ADVM N/A
- AMPG $114.55
- Revenue Next Year
- ADVM $18.82
- AMPG $50.00
- P/E Ratio
- ADVM N/A
- AMPG N/A
- Revenue Growth
- ADVM N/A
- AMPG N/A
- 52 Week Low
- ADVM $1.78
- AMPG $0.64
- 52 Week High
- ADVM $10.14
- AMPG $6.43
- Technical
- Relative Strength Index (RSI)
- ADVM 44.75
- AMPG 54.36
- Support Level
- ADVM $2.11
- AMPG $2.03
- Resistance Level
- ADVM $2.60
- AMPG $2.19
- Average True Range (ATR)
- ADVM 0.22
- AMPG 0.10
- MACD
- ADVM -0.00
- AMPG 0.01
- Stochastic Oscillator
- ADVM 36.39
- AMPG 89.70
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.